IO Biotech, Inc.
NASDAQ:IOBT
1 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 60.031 | 143.193 | 142.59 | 211.531 | 3.405 | 7.846 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 60.031 | 143.193 | 142.59 | 211.531 | 3.405 | 7.846 |
| Net Receivables
| 0 | 1.127 | 1.533 | 2.091 | 1.5 | 1.233 |
| Inventory
| 0 | 0 | -1.533 | -2.091 | 0.359 | 0.221 |
| Other Current Assets
| 1.922 | 2.935 | 4.096 | 8.116 | 0.371 | 0.103 |
| Total Current Assets
| 64.951 | 147.255 | 148.219 | 221.738 | 5.635 | 9.403 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 2.363 | 3.106 | 3.234 | 0.155 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0.268 | 0.268 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.385 | 0.357 | 0.084 | 0.127 | 0.018 | 0.02 |
| Total Non-Current Assets
| 2.748 | 3.463 | 3.586 | 0.55 | 0.018 | 0.02 |
| Total Assets
| 67.699 | 150.718 | 151.805 | 222.288 | 5.653 | 9.423 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 4.661 | 3.878 | 4.004 | 3.928 | 0.522 | 0.997 |
| Short Term Debt
| 0.717 | 0.655 | 1.03 | 0 | 0 | 8.663 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0.948 |
| Other Current Liabilities
| 14.108 | 11.184 | 5.642 | 6.377 | 2.528 | 1.182 |
| Total Current Liabilities
| 19.486 | 15.717 | 10.676 | 10.305 | 3.05 | 10.842 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0 | 1.839 | 2.275 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0.059 | 0 | 22.112 |
| Total Non-Current Liabilities
| 1.198 | 1.839 | 2.275 | 0.059 | 37.906 | 22.112 |
| Total Liabilities
| 20.684 | 17.556 | 12.951 | 10.364 | 40.956 | 32.954 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 37.906 | 22.06 |
| Common Stock
| 0.066 | 0.066 | 0.029 | 0.029 | 0.028 | 0.028 |
| Retained Earnings
| -359.313 | -263.822 | -177.739 | -106.281 | -38.402 | -26.36 |
| Accumulated Other Comprehensive Income/Loss
| -6.851 | -9.669 | -10.141 | -1.489 | 1.961 | 1.297 |
| Other Total Stockholders Equity
| 413.113 | 406.587 | 326.705 | 319.665 | -36.796 | -20.536 |
| Total Shareholders Equity
| 47.015 | 133.162 | 138.854 | 211.924 | -35.303 | -23.531 |
| Total Equity
| 47.015 | 133.162 | 138.854 | 211.924 | -35.303 | -23.531 |
| Total Liabilities & Shareholders Equity
| 67.699 | 150.718 | 151.805 | 222.288 | 5.653 | 9.423 |